News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
186 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors
Dr. Morrison currently serves as the CEO and is a member of the board of directors of Syndax.
November 28, 2017
·
4 min read
GenePOC Launches its GenePOC CDiff Test in the United States
GenePOC is proud to announce the launch of its 2nd FDA cleared assay in less than 6 months, GenePOC CDiff, for use on the revogene instrument.
November 28, 2017
·
5 min read
Aytu BioScience Provides Update on the Continued Growth of Natesto in the U.S.
Significant Natesto prescription growth continued through October 2017, with prescriptions increasing 17% from the previous month, reaching their highest levels to date.
November 28, 2017
·
5 min read
Business
Varian Partners With Penn Medicine for Proton Therapy Training and Education Program
The program will cover all aspects of proton therapy, from patient selection and planning through treatment and follow-up.
November 28, 2017
·
1 min read
Business
Charles River Announces Success of Integrated Discovery Project With ENYO Pharma
ENYO Pharma worked with scientists from Charles River to optimize a potent, novel chemical series (with unknown molecular target) for inhibition of Influenza replication.
November 28, 2017
·
4 min read
Business
Ironwood Appoints New COO and CFO
The company announced the appointment of William Huyett as COO and the promotion of Gina Consylman to senior vice president and CFO.
November 28, 2017
·
6 min read
Policy
PAVmed Files 510(k) Submission With FDA for CarpX Device to Treat Carpal Tunnel Syndrome
Designed to replace invasive surgery and shorten recovery time; addresses an estimated $1 billion market opportunity.
November 28, 2017
·
6 min read
Drug Development
ImmusanT Data Shows Up-Dosing Substantially Increases Nexvax2 Dose Levels That Are Safe and Tolerable, Further Supports Phase II Studies
This study demonstrates that gradually increasing the dose from a low, well-tolerated starting dose enables Nexvax2 to be safe and tolerable without dose-limiting adverse events at a level of 900 μg,.
November 28, 2017
·
5 min read
Business
Applied Photophysics Expands Management Team and Strengthens Sales and Application Support
The Company has also expanded its sales and scientific support teams across the US, UK and Germany with the addition of four Sales Managers and two more Application Scientists
November 28, 2017
·
3 min read
Drug Development
Takeda Initiates Phase I Clinical Trial of Zika Vaccine Candidate
The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 240 subjects between the ages of 18 and 49 across the continental U.S. and U.S. territories.
November 28, 2017
·
8 min read
Previous
5 of 19
Next